Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 7/20 | 0.51 |
| ▸ | CYSLTR1 | Q9Y271 | 7/20 | 0.51 |
| ▸ | BID | P55957 | 3/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.50 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.50 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.50 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.50 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.50 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.50 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | TYR | P14679 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2021545 | 1.00 | CYSLTR2 (0.51) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL2022559 | 1.00 | CYSLTR2 (0.51) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL2024889 | 1.00 | CYSLTR2 (0.51) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL2022891 | 1.00 | CYSLTR2 (0.51) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL2023692 | 0.98 | CYSLTR2 (0.49) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL2023591 | 0.94 | TSHR (0.50) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL2016992 | 0.88 | BID (0.49) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL2021530 | 0.88 | BID (0.49) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL1845694 | 0.88 | BID (0.49) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 | |
| SCHEMBL1843604 | 0.88 | BID (0.49) | CYSLTR2CYSLTR1BIDMCL1BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160476-A1 | N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester | ALKBH3, CPS1, APEH | CYSLTR2 3669/4885CYSLTR1 3698/4885BID 2429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.